Belite Bio (BLTE) Enterprise Value (2021 - 2025)
Belite Bio's quarterly Enterprise Value came in at -$476.8 million in Q4 2025, down 239.1% year-on-year from $342.8 million in Q4 2024, and down 239.1% quarter-over-quarter from -$140.6 million in Q4 2024.
Belite Bio has reported Enterprise Value for 5 years, with the latest figure at -$476.8 million in Q4 2025.
- For the quarter ending Q4 2025, Enterprise Value fell 239.1% year-over-year to -$476.8 million; the trailing twelve-month figure through Dec 2025 stood at -$476.8 million (down 239.1% YoY), and the FY2025 full-year result was -$476.8 million, down 239.1% from the prior year.
- Enterprise Value for Q4 2025 stood at -$476.8 million, down from -$140.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$17.3 million in Q4 2021, with the low at -$476.8 million in Q4 2025.
- Average Enterprise Value over 5 years is -$153.0 million, with a median of -$88.2 million recorded in 2023.
- Year-over-year, Enterprise Value tumbled 59.49% in 2024 and plunged 239.1% in 2025.
- Tracing BLTE's Enterprise Value over 5 years: stood at -$17.3 million in 2021, then sank by 142.67% to -$42.1 million in 2022, then slumped by 109.45% to -$88.2 million in 2023, then plunged by 59.49% to -$140.6 million in 2024, then sank by 239.1% to -$476.8 million in 2025.
- The last three Enterprise Value figures came in at -$476.8 million (Q4 2025), -$140.6 million (Q4 2024), and -$88.2 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.32 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -32.30 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -286.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -61.46 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -2.77 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -7.25 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -18.44 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -8.75 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -3.01 Bn |
| 10 | Belite Bio | 4.92 Bn | 4.45 Bn | - | -476.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -476.78 Mn |
| Sep 30, 2025 | -157.03 Mn |
| Dec 31, 2024 | -140.60 Mn |
| Sep 30, 2024 | -88.16 Mn |
| Dec 31, 2023 | -88.16 Mn |
| Dec 31, 2022 | -42.09 Mn |
| Dec 31, 2021 | -17.34 Mn |